Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Obesity

Exclusive-Wegovy, other weight loss drugs ‘no silver bullet’, says WHO amid obesity review

New highly-effective weight loss drugs such as Novo Nordisk's Wegovy are not a “silver bullet” for addressing the rapid rise in global obesity rates, the World Health Organization’s nutrition chief told Reuters, as the agency conducts its first review of obesity management guidelines in more than 20 years.

Reuters

Scotland's worsening obesity crisis is putting more strain on struggling NHS

Record View says in order to tackle the obesity crisis, we should adopt the mantra of eat less and move more.

Daily Record

East Ayrshire named joint 'obesity capital of Scotland' with grim numbers revealed

Research conducted by New Patients has shown where East, North and South Ayrshire all weigh in.

Daily Record

From analysis to the latest developments in health,
read the most diverse news in one place.

Study reveals why it may not be a good idea to take lengthy naps

‘Not all siestas are the same’

The Independent UK

Study finds obesity as risk factor for colorectal cancer

The risk of colorectal cancer is known to increase with obesity. This association has likely been severely underestimated thus far, according to research from the German Cancer Research Centre (DKFZ). Read further on Dynamite News:

Dynamite News

Obesity in children is rising dramatically, and it comes with major – and sometimes lifelong – health consequences

In the past two decades, children have become more obese and have developed obesity at a younger age. A 2020 report found that 14.7 million children and adolescents in the U.S. live with obesity.

The Conversation

Novo Nordisk, A Top 1% Stock, Dives As Sales Of Obesity Blockbuster Drug Miss

Novo Nordisk stock slumped Thursday after its weight loss blockbuster, Wegovy, missed sales expectations despite rocketing demand.

Investors Business Daily

Read news from The Economist, FT, and more,
with one subscription

Ban smoking and tax fruit juice, says George Osborne

Ex-chancellor urges UK PM extend sugar tax and raise legal age for tobacco to curb obesity and cancer

The Guardian - UK

Obesity linked to increased risk of complications after surgery: Study

In the United States, about 74 per cent of adults aged 20 and older are overweight or obese, with nearly 42 per cent obese. Read further on Dynamite News:

Dynamite News

Woman dies just hours after undergoing liposuction and tummy tuck at hospital

Around 24 hours after going under the knife for liposuction and a tummy tuck at an obesity hospital in Belo Horizonte, Brazil, Gleyciane Alves Maciel Brito went into cardiorespiratory arrest

Daily Mirror

'Complex issue' as quarter of reception children in Nottingham overweight or obese

For children aged 10 to 11, 44.8 per cent were found to be overweight or obese in Nottingham.

Nottingham Post

Can drugs fix the UK’s adolescent obesity crisis?

A powerful new weight-loss medication may be approved for those aged 12 to 17. But healthcare professionals fear it ignores the underlying socioeconomic causes

The Guardian - UK

Children could be prescribed weight-loss jabs on the NHS

Department of Health asks watchdog to assess effectiveness of giving semaglutide to obese youngsters aged 12 to 17

The Guardian - UK

Small businesses offered tax breaks for going green in federal budget – as it happened

This blog is now closed

The Guardian - AU

Get all your
news in one place.

100’s of premium titles.
One news app.

Dynamite News

Bariatric surgery might cut risk of obesity-related cancers: Study

According to a study to be presented at Digestive Disease Week (DDW) 2023, just 4% of patients with obesity who underwent bariatric surgery developed obesity-associated cancer in a 10-year follow-up, compared to 8.9% of those who did not have a weight-loss treatment. Read further on Dynamite News:

Investors Business Daily

Lilly Has Plans For Possible Anti-Obesity Medication. Here's How To Make Money With LLY Options

This trade is a neutral to bullish position and anticipates the stock holding above 390 over the summer term.

Daily Record

New weight loss drug helping people lose 2.5 stone is 'coming to the UK'

A weekly injection of tirzepatide has seen people with obesity and diabetes lose over 15 percent of their bodyweight.

Daily Mirror

Fat-fighting jab that helps you shed 100lbs in just a few months could be coming to UK

Since the drug was first approved last year, thousands of patients have obtained the drug from doctors and telehealth providers who prescribed it "off-label" to help them slim down

Get all your
news in one place.

100’s of premium titles.
One news app.

Chicago Sun-Times

Young Latinas are seeing a staggering rise in uterine cancer — and experts don’t know why

Uterine cancer is generally more common in older women and is long known to disproportionately strike Black women. Now, new research adds to growing evidence that uterine cancer also is rising rapidly among reproductive-aged Hispanic women.

The Independent UK

What to know about prescription drugs promising weight loss

Obesity is a major and growing problem around the world, but especially in the U.S. Researchers have long looked for medications that can help people lose weight, mostly with disappointing and, in some cases, dangerous results

Salon

Social Media adds to weight loss craze

GLP-1 agonists are a class of weight loss drug that is going viral on social media — but misinformation is rife

WEKU

Eli Lilly releases more data for new obesity drug, moving toward fast-track approval

There's already a huge demand for existing weight-loss drugs, so the new medication is highly anticipated. Obesity affects an estimated 650 million adults globally.

The Independent UK

Powerful new obesity drug poised to upend weight loss care

A diabetes drug being tested for weight loss is poised to further upend obesity care

Businessweek

Good Luck Paying for Those $10,000 Obesity Drugs Everyone’s Talking About

Ozempic, Wegovy and Mounjaro can cause dramatic weight loss, and could create a market worth $150 billion a year.

The Independent UK

Why key to curing diabetes could be NHS-prescribed soups and shakes

‘Obesity is a significant factor and cause of several serious diseases’ warns NHS’ diabetes chief

1 … 28 29 30 31

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

World Health Organization

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.